Recruiting nowPhase 3
Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)
Updated 2026-09-02 · NCT07083154See eligibility →
Treatment
Active studies that list Mazdutide as an intervention or treatment.
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.